Over £65 million has been awarded to seven business-led projects aimed at developing therapeutic and diagnostic technologies that use nanotechnology

Over £65 million has been awarded by the Engineering and Physical Sciences Research Council and the Technology Strategy Board to seven business-led projects aimed at developing therapeutic and diagnostic technologies that use nanotechnology. The aim is to make the UK an early competitive adopter of these technologies as well as supporting the commercialisation of ideas at their early stages.

This investment is part of a two stage initiative under the Nanoscience Through Engineering to Application Grand Challenge for Healthcare and the projects will be led by Critical Pharmaceuticals, Johnson Matthey, Mologic, Nanomerics, OJ-Bio, Renishaw Diagnostics and Sharp Laboratories of Europe.